IL211810A0 - Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis - Google Patents
Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitisInfo
- Publication number
- IL211810A0 IL211810A0 IL211810A IL21181011A IL211810A0 IL 211810 A0 IL211810 A0 IL 211810A0 IL 211810 A IL211810 A IL 211810A IL 21181011 A IL21181011 A IL 21181011A IL 211810 A0 IL211810 A0 IL 211810A0
- Authority
- IL
- Israel
- Prior art keywords
- ribavirin
- interferon
- hepatitis
- peg
- treatment
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title 1
- 108010050904 Interferons Proteins 0.000 title 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 229940079322 interferon Drugs 0.000 title 1
- 229960000329 ribavirin Drugs 0.000 title 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 title 1
- 229960002935 telaprevir Drugs 0.000 title 1
- 238000011285 therapeutic regimen Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9984908P | 2008-09-24 | 2008-09-24 | |
| US10965508P | 2008-10-30 | 2008-10-30 | |
| US24304109P | 2009-09-16 | 2009-09-16 | |
| PCT/US2009/058218 WO2010036799A1 (en) | 2008-09-24 | 2009-09-24 | Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis " |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL211810A0 true IL211810A0 (en) | 2011-06-30 |
Family
ID=41396114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL211810A IL211810A0 (en) | 2008-09-24 | 2011-03-17 | Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20110236351A1 (enExample) |
| EP (1) | EP2328656A1 (enExample) |
| JP (1) | JP2012503669A (enExample) |
| KR (1) | KR20110074870A (enExample) |
| CN (1) | CN102316935A (enExample) |
| AU (1) | AU2009296653A1 (enExample) |
| CA (1) | CA2738477A1 (enExample) |
| EA (1) | EA201170484A1 (enExample) |
| IL (1) | IL211810A0 (enExample) |
| MX (1) | MX2011003121A (enExample) |
| WO (1) | WO2010036799A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8399615B2 (en) | 2005-08-19 | 2013-03-19 | Vertex Pharmaceuticals Incorporated | Processes and intermediates |
| CA2740728A1 (en) * | 2008-10-15 | 2010-04-22 | Intermune, Inc. | Therapeutic antiviral peptides |
| EP2396028A2 (en) * | 2009-02-12 | 2011-12-21 | Vertex Pharmceuticals Incorporated | Hcv combination therapies comprising pegylated interferon, ribavirin and telaprevir |
| WO2011041551A1 (en) * | 2009-10-01 | 2011-04-07 | Intermune, Inc. | Therapeutic antiviral peptides |
| US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
| DE112012003457T5 (de) | 2011-10-21 | 2015-03-12 | Abbvie Inc. | Kombinationsbehandlung (z.B. mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV) |
| US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
| TWI532487B (zh) | 2011-10-21 | 2016-05-11 | 艾伯維有限公司 | 治療ｃ型肝炎病毒（ｈｃｖ）之方法 |
| CN109689063A (zh) | 2016-04-28 | 2019-04-26 | 埃默里大学 | 含有炔烃的核苷酸和核苷治疗组合物及其相关用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG153800A1 (en) * | 2004-06-08 | 2009-07-29 | Vertex Pharma | Pharmaceutical compositions |
| MY141025A (en) * | 2004-10-29 | 2010-02-25 | Vertex Pharma | Dose forms |
| CA2650616A1 (en) * | 2006-04-26 | 2007-11-08 | Vertex Pharmaceuticals Incorporated | Hepatitis c virus infection biomarkers |
| WO2008144072A1 (en) * | 2007-05-21 | 2008-11-27 | Vertex Pharmaceuticals Incorporated | Dose forms comprising vx- 950 and their dosage regimen |
-
2009
- 2009-09-24 AU AU2009296653A patent/AU2009296653A1/en not_active Abandoned
- 2009-09-24 CA CA2738477A patent/CA2738477A1/en not_active Abandoned
- 2009-09-24 WO PCT/US2009/058218 patent/WO2010036799A1/en not_active Ceased
- 2009-09-24 EP EP09792953A patent/EP2328656A1/en not_active Withdrawn
- 2009-09-24 CN CN2009801480304A patent/CN102316935A/zh active Pending
- 2009-09-24 JP JP2011529223A patent/JP2012503669A/ja active Pending
- 2009-09-24 EA EA201170484A patent/EA201170484A1/ru unknown
- 2009-09-24 KR KR1020117008799A patent/KR20110074870A/ko not_active Withdrawn
- 2009-09-24 MX MX2011003121A patent/MX2011003121A/es not_active Application Discontinuation
-
2011
- 2011-03-17 IL IL211810A patent/IL211810A0/en unknown
- 2011-03-24 US US13/070,991 patent/US20110236351A1/en not_active Abandoned
-
2012
- 2012-12-18 US US13/718,608 patent/US8871812B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010036799A1 (en) | 2010-04-01 |
| EP2328656A1 (en) | 2011-06-08 |
| KR20110074870A (ko) | 2011-07-04 |
| JP2012503669A (ja) | 2012-02-09 |
| AU2009296653A1 (en) | 2010-04-01 |
| CN102316935A (zh) | 2012-01-11 |
| US20110236351A1 (en) | 2011-09-29 |
| CA2738477A1 (en) | 2010-04-01 |
| US8871812B2 (en) | 2014-10-28 |
| EA201170484A1 (ru) | 2012-03-30 |
| MX2011003121A (es) | 2011-04-21 |
| US20130101554A1 (en) | 2013-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL211810A0 (en) | Therapeutic regimen comprising peg- interferon, ribavirin and vx-950 for the treatment of hepatitis | |
| AP2907A (en) | Viral hepatitis treatment | |
| EP2318031A4 (en) | IMPROVED METHODS AND DEVICES FOR ANTIVIRAL THERAPY | |
| GB0602178D0 (en) | Therapeutic treatment | |
| IL213070A0 (en) | Methods for the treatment of infections and tumors | |
| EP2343066A4 (en) | THERAPEUTIC AGENT FOR HEPATITIS C | |
| GB0700436D0 (en) | Impulse therapy for enhanced blood circulation in the body | |
| IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
| HUE037109T2 (hu) | Endoxifén rák kezelésében történõ alkalmazásra | |
| GB0807018D0 (en) | Antibodies and treatment | |
| EP2004154A4 (en) | THERAPEUTIC BELT | |
| IL218279A0 (en) | Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin | |
| ZA200901452B (en) | Treatment of vertigo with acetyl-L-leucine | |
| ZA201000225B (en) | Treatment of depression | |
| GB0608655D0 (en) | Therapeutic Treatment | |
| IL200032A0 (en) | Medicament for the treatment of endometriosis | |
| GB0816650D0 (en) | Therapeutic bone grwth and regeneration | |
| BRPI0714318A2 (pt) | Utilização de 2-benzoil-imidazopiridinas em terapêutica | |
| IL213593A0 (en) | Hepatitis c virus combination therapy | |
| PL2330892T3 (pl) | Sposoby leczenia z zastosowaniem leków wychwytujących amoniak | |
| GB0610909D0 (en) | Therapeutic treatment | |
| EP1881828A4 (en) | TREATMENT OF HEPATITIS C (HCV) USING SUB-THERAPEUTIC DOSES OF RIBAVIRIN | |
| ZA200809012B (en) | Intravenous antiviral treatments | |
| ZA200905300B (en) | Medicament for the treatment of endometriosis | |
| FI8286U1 (fi) | Kunto- ja terapiaväline |